Eli Lilly and Company to Participate in Morgan Stanley's 23rd Annual Global Healthcare Conference
Reuters
Aug 25
Eli Lilly and Company to Participate in <a href="https://laohu8.com/S/MTK">Morgan Stanley</a>'s 23rd Annual Global Healthcare Conference
Eli Lilly and Company will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025. Jacob Van Naarden, executive vice president and president of Lilly Oncology, along with David Hyman, M.D., Lilly's chief medical officer, will engage in a fireside chat during the event.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eli Lilly and Company published the original content used to generate this news brief via PR Newswire (Ref. ID: DE56816) on August 25, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.